drugs
-
Singulair (montelukast sodium)
Singulair — another in a new class of drugs called leukotriene inhibitors — was approved by the U.S. Food and Drug Administration (FDA) for the long-term treatment of chronic asthma. This once-a-day pill offers a new weapon in the fight against asthma symptoms. And unlike other drugs in this class, this one can be taken […]
-
Osteoporosis - medical treatment
Today’s drugs can slow bone loss, and even reverse it.
-
Evista (Raloxifene)
In December 22, 1997, the U.S. Food and Drug Administration (FDA) approved the drug raloxifene for the prevention of the bone-weakening disease osteoporosis. Dr. Kimberley Mulvihill, an obstetrician and gynecologist, talks about how raloxifene works and who might best benefit from its use.